NEW STUDY. People with type 2 diabetes are at significantly elevated risk of needing intensive care if they get COVID-19. This is shown by a study comprising data on 2.6 million Swedes, of whom half a million are on the diabetes register. The study also indicates increased mortality from COVID-19 among type 2 diabetics. In Sweden, about half a million people have diabetes, and 90 percent of them have type…
Good long-term effects of continuous glucose monitoring
NEW STUDY. New data on continuous glucose monitoring for people with type 1 diabetes, over a significantly longer period than before, are now available. A University of Gothenburg study shows that using the CGM tool, with its continuous monitoring of blood sugar (glucose) levels, has favorable effects over several years. The technology of continuous glucose monitoring (CGM) is superseding that of the classic portable blood glucose meters, which require a…
A molecule from gut bacteria reduces effect of diabetes medication
NEW STUDY. The action of metformin, the classic drug used to treat diabetes by stabilizing blood sugar, can be blocked by a molecule from the bacteria in our intestines, a University of Gothenburg study shows. Metformin is the primary treatment option for type 2 diabetes, but there are major variations in how individuals respond to this drug. In some people it lowers blood glucose (sugar) and delays the course of…
ERC Consolidator Grant to diabetes researcher Anders Rosengren
GRANTS. Anders Rosengren, a diabetes researcher at the Institute of Neuroscience and Physiology, is one of the recipients of the ERC Consolidator Grant for his research on type 2 diabetes. The European Research Council is providing him with SEK 20 million for his research, which can eventually result in more patients receiving customized treatment for their unique type of diabetes. As a researcher at University of Gothenburg, Anders Rosengren participates…
Interview with this year’s recipient of the Young Fernström Prize: Marcus Lind
DISTINCTION. Marcus Lind, a chief physician and newly appointed professor, has conducted research that has had a significant impact on several guidelines in diabetes care around the world. By participating in major epidemiological research projects while meeting with patients clinically, he is at the forefront of the translational research method. Now he has been awarded the Young Fernström Prize, which is presented to young, highly promising and successful researchers. Marcus…